C. VAISLIC, A. BENJELLOUN, J.-N. FABIANI, J.-F. BONNEVILLE, S. CHOCRON
Abstract
Current treatment of thoracoabdominal aneurysms is associated with significant morbidity and mortality. The most feared and devastating complication is paraplegia accompanied by sphincter and posture problems. To try and reduce these complications we have treated patients with multilayer flow modulators which preserve collateral circulation and branch patency. The multilayer flow modulation concept offers a completely novel approach to thoracoabdominal aneurysm treatment. Aneurysms are excluded physiologically rather than mechanically while preserving vital collateral circulation and enhancing branch patency. Here we present the key principles of the hemodynamic flow modulation concept and its application in peripheral aneurysms as well as FIM cases for the treatment of thoracoabdominal aneurysms. The enrollment of a non randomized multi-center trial with the Cardiatis multilayer flow modulator, for thoracoabdominal aortic aneurysm patients, with no alternative treatment, is currently being completed in France.
Mortality following surgical treatment of TAAA averages between 6% and 15% for elective procedures and between 50% to 60% for emergency operations 1-3. With 15% morbidity for elective procedures, complications are often major with significant risk of renal failure and respiratory insufficiency. This prolongs IC time. Paraplegia is the most feared and devastating complication and frequently leads to sphincter and posture problems. In all cases it is a severe invalidity and in France, since the law of 4th March 2002, leads to systematic claims for compensation before the CRCIs (regional medical accident compensation boards). To reduce these complications adjuvant therapies have been proposed: distal aortic perfusion by circulation bypass or passive shunt 4-6 profound general or local hypothermia with circulatory shutdown, drainage of the cephalorachidian fluid, re-attachment of the Adamkiewicz artery or intercostal arteries as well as postoperative surveillance 7, 8. In every interventional cardiovascular reference work, complete chapters are dedicated to this issue, and whole sessions are dedicated to this at international congresses.
The results of endovascular treatment for infrarenal and descending thoracic aortic aneurysms are now comparable with standard open surgical procedure. However, endovascular repair in the thoracoabdominal aorta has been limited due to the complexity of keeping visceral and renal arteries perfused. Attempts are being made to adapt endoluminal stent-grafts by using custom fenestrations and branched grafts. While preliminary data shows concept feasibility, these techniques are still investigational and require highlyskilled endovascular specialists and custom-made devices 7.
Should this device prove to be efficacious, this type of intervention could readily become more available to patients, due to the device’s ease of use and its ability to be used by more medical professionals (including vascular surgeons and interventional radiologists) than the treatment alternatives.
Fig. 74.3. – FU 6 months – exclusion of aneurysm and perfused collaterals and patent branches.
Fig. 74.4. – 30 month FU showing the 2 patent branches. Dr. Antonios Polydorou, Cardiologist, Evangelismos Hospital Athens. Greece.
Fig. 74.5. – SM aneurysm treated with Cardiatis multilayer flow modulator, post implant and FU at 1Y. Dr. Sameer Dani, Cardiologist, Life care Institute of Medical Science & Research, Ahmedabad, India.
04. Patel HJ, Upchurch GR Jr, Eliason JL, Criado E, Rectenwald J, Williams DM, Deeb GM. Hybrid debranching with endovascular repair for thoracoabdominal aneurysms: a comparison with open repair. Ann Thorac Surg 2010;89(5):1475-81.
05. Ferrero E, Ferri M, Viazzo A, Gaggiano A, Maggio D, Berardi G, Piazza S, Cumbo P, Pecchio A, Lamorgese V. Hybrid open and endovascular repair of recurrent visceral aortic patch aneurysmal expansion after previous thoracoabdominal aortic aneurysm repair: case report and description of technique. Minerva Chir 2010;65(3):393-400.
06. Biasi L, Ali T, Loosemore T, Morgan R, Loftus I, Thompson M. Hybrid repair of complex thoracoabdominal aortic aneurysms using applied endovascular strategies combined with visceral and renal revascularization. J Thorac Cardiovasc Surg 2009;138(6):1331-8.
07. Kieffer E, Chiche L, Godet G, Koskas F, Bahnini A, Bertrand M, Fléron MH, Goarin JP, Warnier de Wailly G, Benhamou AC. Type IV thoracoabdominal aneurysm repair: predictors of postoperative mortality, spinal cord injury, and acute intestinal ischemia. Ann Vasc Surg 2008;22(6): 822-8.
08. Chocron S, Vaislic C, Bonneville JF. Multilayer stents in the treatment of chronic type B dissection. Annals of thoracic surgery, in press.
30/ Remplacement combiné de l’aorte ascendante et de la valve aortique
31/ Opération de Bentall
Sociétés scientifiques
Sociétés françaises :
Société française de Chirurgie Cardiovasculaire et Thoracique, Membre titulaire élu
Collège de Chirurgie Vasculaire Collège Français de Chirurgie Thoracique et Cardiovasculaire Compagnie des experts près la cour d‘appel de Versailles , les cours administratives d‘appel de Paris et Versailles Secrétaire général adjoint de la Société Française d‘Angiologie
Sociétés étrangères :
Fellow of the European Board of Thoracic and Cardiovascular Surgery
Récompenses du Dr Claude Vaislic
Françaises :
Lauréat de la Fondation “Le pied à l‘étrier”
Lauréat de la Faculté de Médecine (Médaille d‘Or, Major 1ère année de médecine,)
Lauréat de la Faculté de Médecine (Médaille d‘Or, Major 2 ème année de médecine)
Lauréat de la Faculté de Médecine (Médaille d‘Or de thèse)
Étrangères :
Physician Recognition Award AMERICAN MEDICAL ASSOCIATION
Titres étrangers du Dr Claude Vaislic
Educational Commission for Foreign Medical Graduates, PARIS
Federal License Examination: Flex. INDIANAPOLIS,
Visa Qualification Examination: V.Q.E., NEW YORK
License médicale dans l‘état de Floride, U.S.A., no. ME 39410
Drug Enforcement Administration no. AV1456703
Advance Cardiac Life Support: AMERICAN HEART ASSOCIATION
License Médicale au Royaume Unis et inscription sur la liste de spécialistes: General Médical Council Registration no. 4475488
Fellow of the European Board of Thoracic and Cardiovascular Surgery
Titres hospitaliers du Dr Claude Vaislic
Interne des Hôpitaux
Chef de Clinique-Assistant des Hôpitaux
Attaché des Hôpitaux Chirurgie Thoracique et Cardiovasculaire
Inscrit sur la liste d‘aptitude de Praticien Hospitalier en Chirurgie Thoracique et Cardiovasculaire